China is building a weapon that could bring the United States to its knees without firing a single shot. It’s taking over global pharmaceutical development – and gaining unprecedented control of the medical innovations Americans depend on. Chinese companies account for nearly a third of drugs currently in development, and China recently surpassed the United States in conducting clinical trials. By 2040, China is projected to be responsible for over a third of new FDA approval

For decades, Washington has treated the decline in smoking as a public health success story—and it is. Rates are down. Awareness is up. The cultural shift is undeniable. But the job isn’t finished. It’s just become less visible. A new white paper from Philip Morris International’s U.S. arm makes a point that policymakers have largely ignored: America didn’t end smoking. It concentrated it among the hardest-to-reach populations—working-class Americans, rural communities, and t